Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Cash from Financing Activities (2020 - 2025)

Privia Health (PRVA) has 6 years of Cash from Financing Activities data on record, last reported at $2.1 million in Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 246.53% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $6.7 million, up 54.64%, while the annual FY2025 figure was $6.7 million, 54.64% up from the prior year.
  • Cash from Financing Activities reached $2.1 million in Q4 2025 per PRVA's latest filing, up from $431000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $210.8 million in Q2 2021 and bottomed at -$30.9 million in Q2 2022.
  • Average Cash from Financing Activities over 5 years is $10.4 million, with a median of $1.5 million recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 48229.91% in 2021, then crashed 114.66% in 2022.
  • A 5-year view of Cash from Financing Activities shows it stood at $3.2 million in 2021, then crashed by 38.15% to $2.0 million in 2022, then tumbled by 97.85% to $42000.0 in 2023, then skyrocketed by 1373.81% to $619000.0 in 2024, then skyrocketed by 246.53% to $2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $2.1 million in Q4 2025, $431000.0 in Q3 2025, and $1.9 million in Q2 2025.